Neuron23
Combining cutting-edge science, human genetics, and a patient-centered approach to transform how we treat Parkinson’s.
28 employees · est. 2018 · South San Francisco, United...
Satori Pharmaceuticals
Pioneering advanced therapies for Alzheimer's, Parkinson's, and other neurodegenerative diseases.
est. 2005
Satori Pharmaceuticals is the older company (2018 vs 2005).
Side-by-Side Comparison
| Metric | Neuron23 | Satori Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2005 older |
| Headquarters | ||
| Headquarters | South San Francisco, United States | Not tracked yet |
| Employees | ||
| Employees | 28 | Not tracked yet |
| Industry | ||
| Industry | Not tracked yet | Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series D | Series Unknown |
| Total Funding | ||
| Total Funding | $230.00M | $47.32M |
| Funding Rounds | ||
| Funding Rounds | 4 | 5 |
| Services | ||
| Services | Development of precision medicine for Parkinson's Disease, Clinical trials for novel therapeutic approaches, Research and development in neuroimmunology and neuroscience | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with Parkinson's Disease, Healthcare providers specializing in neurology, Pharmaceutical and biotechnology investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Precision Medicine, Parkinson's Disease, Neurodegenerative Diseases, Human Genetics, Biomarker Platform, Drug Discovery, Neurological Diseases, Alzheimer's Disease, Clinical-stage Biotechnology, Hyperactive LRRK2, Patient-centered Approach, Neuroinflammatory Diseases, Autoimmune Diseases | Neuroscience, Alzheimer's, Parkinson's, Disease-modifying Therapies, Neurodegenerative Diseases, Pharmaceuticals, Drug Discovery, Disease Research, Neurological Disorders |
| Website | ||
| Website | neuron23.com | satoripharma.com |
About Neuron23
Neuron23, founded in 2018, is a clinical-stage biotechnology company based in the United States. The company is pioneering advancements in precision medicine, specifically targeting Parkinson’s disease driven by hyperactive LRRK2. By integrating cutting-edge science with human genetics and its propr...
About Satori Pharmaceuticals
Satori Pharmaceuticals, founded in 2005, is a neuroscience company dedicated to pioneering advanced therapies for Alzheimer's, Parkinson's, and other neurodegenerative diseases. The company's slogan, "Pioneering advanced therapies for Alzheimer's, Parkinson's, and other neurodegenerative diseases,"...
We will tell you when either one moves
BounceWatch watches Neuron23 and Satori Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Neuron23 and Satori Pharmaceuticals — by email.
Frequently Asked Questions
Compare Neuron23 with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Neuron23 on 31 Mar 2026, and Satori Pharmaceuticals on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.